2020
Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers
D'Angelo H, Ramsey AT, Rolland B, Chen LS, Bernstein SL, Fucito LM, Hooper M, Adsit R, Pauk D, Rosenblum MS, Cinciripini PM, Joseph A, Ostroff JS, Warren GW, Fiore MC, Baker TB. Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers. Frontiers In Public Health 2020, 8: 221. PMID: 32596200, PMCID: PMC7304341, DOI: 10.3389/fpubh.2020.00221.Peer-Reviewed Original ResearchConceptsTobacco treatment servicesCancer care settingsNational Cancer InstituteRE-AIM frameworkCancer CenterCare settingsTreatment servicesElectronic health recordsCessation servicesCessation outcomesCancer Center Cessation InitiativeCessation service deliveryDelivery of tobaccoPatients' tobacco useTobacco treatment programTobacco cessation programBetter patient outcomesCurrent smokersCessation initiativesTobacco treatmentTobacco cessationPatient populationCessation programsTreatment referralPatient outcomes
2019
Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment
Baldassarri SR, Fiellin DA, Savage ME, Madden LM, Beitel M, Dhingra LK, Fucito L, Camenga D, Bollampally P, Barry DT. Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment. Drug And Alcohol Dependence 2019, 197: 37-41. PMID: 30769264, PMCID: PMC6637405, DOI: 10.1016/j.drugalcdep.2018.12.012.Peer-Reviewed Original ResearchConceptsOpioid use disorderOpioid agonist therapyCurrent cigarette smokingCigarette smokingEC useHigher oddsFormer smokersLower oddsPsychiatric distressPast cigarette smokingElectronic cigarette useAgonist therapyCurrent smokersBuprenorphine treatmentChronic painTobacco useNicotine dependenceUse disordersSmokingCigarette useMultivariate analysisElectronic cigarettesSmokersCigarettesMultivariate model
2017
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer
Bold KW, Toll BA, Cartmel B, Ford BB, Rojewski AM, Gueorguieva R, O'Malley SS, Fucito LM. Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer. The Journal Of Smoking Cessation 2017, 13: 244-247. PMID: 32431757, PMCID: PMC7236885, DOI: 10.1017/jsc.2017.24.Peer-Reviewed Original ResearchLung cancerTobacco treatmentBiomarker feedbackCessation/reductionStandard careExpired carbon monoxideLung cancer screeningPoint prevalence abstinenceCurrent smokersLung functionPrimary outcomeCessation ratesCessation therapyCancer screeningQuit ratesSkin carotenoidsPlasma bilirubinGain-framed messagesNovel biomarkersPatientsNovel interventionsCancerPast weekSequential interventionsGain-framed messaging
2016
Resting-State Functional Connectivity of the Basal Nucleus of Meynert in Cigarette Smokers: Dependence Level and Gender Differences
Zhang S, Hu S, Fucito LM, Luo X, Mazure CM, Zaborszky L, Li CR. Resting-State Functional Connectivity of the Basal Nucleus of Meynert in Cigarette Smokers: Dependence Level and Gender Differences. Nicotine & Tobacco Research 2016, 19: 452-459. PMID: 27613921, PMCID: PMC6074817, DOI: 10.1093/ntr/ntw209.Peer-Reviewed Original ResearchConceptsSupplementary motor areaCigarette smokersCholinergic systemCigarette smokingFemale smokersMotor areaBasal nucleusFunctional connectivityResting-state functional connectivityGender-matched nonsmokersWhole-brain functional connectivityNicotine dependence scoresBilateral anterior insulaNicotinic acetylcholine receptorsPosterior cingulate cortexCurrent smokersMale smokersCerebral cortexCholinergic projectionsMultiple imaging modalitiesBasal forebrainGreater negative connectivitySex-specific differencesSmokersFagerström Test